8193219

3 known cases. View patent page →

Cases
3
Active
0
3 closed
Filed
2018–2019
Top venue
D N J
3 cases

Celgene Corporation v. Cipla Limited

settled/consolidated
Docket:
2:18-cv-08964
Court:
D.N.J.
Filed:
2018-05-08
Terminated:
2020-12-11

Celgene sued Cipla over lenalidomide, and on Apr. 30, 2019 Cipla stipulated it would not contest infringement of the '357, '219, and '598 patents while reserving invalidity. The case was administratively terminated and consolidated into 2:19-cv-14731 on June 8, 2020, and ultimately settled Dec. 11, 2020.

Celgene Corp. v. Cipla Ltd.

settled
Docket:
2:19-cv-14731
Court:
D.N.J.
Filed:
2019-07-03

Celgene's consolidated action against Cipla consolidated 2:17-cv-06163 and 2:18-cv-08964. It settled in Dec. 2020; the consolidated Cipla action carried the '357, '219, and '598 patents from 2:18-cv-08964.